VOLUME 34 NUMBER 10 OCTOBER 2016 nature biotechnology l e t t e r s Blood pressure regulation is known to be maintained by a neuro-endocrine circuit, but whether immune cells contribute to blood pressure homeostasis has not been determined. We previously showed that CD4 + T lymphocytes that express choline acetyltransferase (ChAT), which catalyzes the synthesis of the vasorelaxant acetylcholine, relay neural signals 1 . Here we show that these CD4 + CD44 hi CD62L lo T helper cells by gene expression are a distinct T-cell population defined by ChAT (CD4 T ChAT ). Mice lacking ChAT expression in CD4 + cells have elevated arterial blood pressure, compared to littermate controls. Jurkat T cells overexpressing ChAT (JT ChAT ) decreased blood pressure when infused into mice. Co-incubation of JT ChAT and endothelial cells increased endothelial cell levels of phosphorylated endothelial nitric oxide synthase, and of nitrates and nitrites in conditioned media, indicating increased release of the potent vasorelaxant nitric oxide. The isolation and characterization of CD4 T ChAT cells will enable analysis of the role of these cells in hypotension and hypertension, and may suggest novel therapeutic strategies by targeting cellmediated vasorelaxation.
l e t t e r s
Blood pressure regulation is known to be maintained by a neuro-endocrine circuit, but whether immune cells contribute to blood pressure homeostasis has not been determined. We previously showed that CD4 + T lymphocytes that express choline acetyltransferase (ChAT), which catalyzes the synthesis of the vasorelaxant acetylcholine, relay neural signals 1 . Here we show that these CD4 + CD44 hi CD62L lo T helper cells by gene expression are a distinct T-cell population defined by ChAT (CD4 T ChAT ). Mice lacking ChAT expression in CD4 + cells have elevated arterial blood pressure, compared to littermate controls. Jurkat T cells overexpressing ChAT (JT ChAT ) decreased blood pressure when infused into mice. Co-incubation of JT ChAT and endothelial cells increased endothelial cell levels of phosphorylated endothelial nitric oxide synthase, and of nitrates and nitrites in conditioned media, indicating increased release of the potent vasorelaxant nitric oxide. The isolation and characterization of CD4 T ChAT cells will enable analysis of the role of these cells in hypotension and hypertension, and may suggest novel therapeutic strategies by targeting cellmediated vasorelaxation.
A major physiological mechanism of blood pressure regulation is through modulation of blood flow by alterations in vessel diameter. Acetylcholine, a signaling molecule produced by neurons and lymphocytes, is a vasorelaxant that decreases blood vessel resistance and reduces blood pressure 2 . Binding to cognate cholinergic receptors on endothelial cells, acetylcholine stimulates phosphorylation of endothelial nitric oxide synthase (eNOS), the rate-limiting enzyme in the biosynthesis of nitric oxide (NO). Endothelium-derived NO diffuses into smooth muscle cells in the vascular wall, where it interacts with the heme-containing protein guanylate cyclase to induce synthesis of cGMP. This secondary messenger down-modulates availability of intracellular calcium required for myosin phosphorylation, leading to relaxation of vascular smooth muscle cells, and decreased blood pressure. Paradoxically, most arteries are innervated by adrenergic nerves, and vascular endothelial cells do not receive major direct input from acetylcholine-secreting neurons [3] [4] [5] .
While studying the neural regulation of immunity, we previously identified a specific role for lymphocyte-derived acetylcholine in relaying neural signals in the inflammatory reflex 1 . A subset of T cells in spleen and other tissues expresses ChAT, the rate-limiting enzyme for the biosynthesis of acetylcholine 1, 6, 7 . Here, we characterize these cells further and determine whether ChAT-expressing CD4 + cells provide a cellular mechanism for vasorelaxation in the regulation of blood pressure.
To characterize the ChAT-expressing T cells, we used fluorescenceactivated cell sorting (FACS) to isolate splenic ChATeGFP + CD4 + CD44 hi CD62L lo T lymphocytes from transgenic mice expressing enhanced green fluorescence protein (eGFP) under the control of regulatory elements for expression of ChAT 1, 8 . These acetylcholine-producing memory T cells have been shown to control innate immune responses and constitute <10% of the CD4 + CD44 hi CD62L lo population in spleen 1 . Comparison to ChATeGFP − CD 4+ CD44 hi CD62L lo T lymphocytes by microarray analysis using Affymetrix Gene 1.0 ST arrays and unsupervised hierarchical clustering of the complete transcriptome showed that ChAT-eGFP − and ChAT-eGFP + cells formed distinct clusters (Fig. 1a) . Transcript expression in ChAT-eGFP + subsets differed considerably as compared to ChAT-eGFP − subsets (Fig. 1b) . Analysis of the significant differences using the Gene Ontology enrichment analysis and visualization Blood pressure regulation by CD4 + lymphocytes expressing choline acetyltransferase l e t t e r s npg l e t t e r s tool (GOrilla) 9 revealed that genes modulating immune process regulation and negative regulation of leukocyte activation were highly overrepresented ( Supplementary Fig. 1) ; and genes modulating G-protein-coupled signaling were downregulated ( Supplementary  Fig. 2 ) in the ChAT-eGFP + population. Analysis using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database by the DAVID Bioinformatics tools [10] [11] [12] showed over-representation of genes implicated in cytokine-cytokine receptor interaction (Supplementary Table 1 ) in the ChAT-eGFP + population. ChAT expression in ChATeGFP + T lymphocytes was compared against that in 198 different immune cell subsets in the ImmGen data set 13 (cell types listed in Supplementary Table 2 ). The ChAT-eGFP + T-cell subset expressed ChAT at considerably higher levels as compared to the other subsets ( Fig. 1c and Supplementary Table 3 ). Microarray analysis using unsupervised hierarchical clustering demonstrated that ChAT-eGFP + T lymphocytes clustered with CD4 + CD44 hi and Foxp3-expressing T lymphocytes (Fig. 1c) .
ChAT-eGFP + T cells within the CD4 + CD44 hi CD62L lo T helper cell population defined a unique branch, distinct from other splenic T lymphocyte subsets in hierarchical clustering (Fig. 1d) . Pairwise Euclidean distance plots of complete gene expression revealed that ChAT-eGFP + T lymphocytes were highly segregated (Fig. 1e) . Principal component analysis showed that ChAT-eGFP + T lymphocytes harbored a T-cell gene signature ( Supplementary Fig. 3 and Supplementary  Table 4 ), but differed as compared to other T lymphocyte subsets by the first principal component (Fig. 1f) . Gene ontology classification demonstrated that genes implicated in regulation of leukocyte activation, cytokine receptor activity, and G-protein-coupled receptor activity were highly over-represented ( Supplementary Figs. 4 
and 5).
Pairwise comparison against 13 other T lymphocyte subsets in the ImmGen database showed that from the cohort of transcription factors implicated in T-cell differentiation 14 , 41 were highly over-or under-represented in the ChAT-eGFP + T lymphocyte subset (Supplementary Fig. 6 ). We refer to these ChAT + CD4 + T cells as CD4 T ChAT cells.
We collected tail vein blood from ChAT-eGFP mice and found that ChAT-eGFP + T lymphocytes represented 1.1% of total circulating CD3 + cells (median 95% confidence interval: 0.5-2%) (Fig. 2a) . To study whether this relatively small number of lymphocytes modulates blood pressure, we used Cre-loxP recombination in mice to selectively ablate ChAT in CD4 + cells. Mice expressing Cre recombinase under the control of the endogenous CD4 promoter (CD4-Cre) were crossed with mice having loxP-flanked ChAT (ChAT-floxed) to generate offspring deficient in ChAT-expressing-T cells (CD4 ChAT − ). We obtained continuous recordings of carotid blood pressure in awake, freely moving CD4 ChAT − and littermate CD4 ChAT + mice using telemetry. Both strains displayed normal and similar diurnal blood pressure variation. Systolic, diastolic, and mean arterial pressures were significantly higher in CD4 ChAT − as compared to littermate CD4 ChAT + mice (P = 0.02, P = 0.02, P = 0.01, respectively) ( Fig. 2b and Supplementary Figs. 7  and 8 ). Blood pressure recordings as mean arterial tail cuff blood pressure in another group of CD4 ChAT − and CD4 ChAT + mice were also significantly higher in CD4 ChAT − mice as compared to littermate CD4 ChAT + controls (113 ± 3 mm Hg, n = 23 vs. 103 ± 4 mm Hg, n = 17, P = 0.028) (Supplementary Fig. 9 ). Finally, blood pressure measured through an indwelling left carotid artery catheter during anesthesia was also significantly higher in CD4 ChAT − as compared to littermate CD4 ChAT + mice (Fig. 2c) . Heart rate was unchanged or decreased in Figs. 10 and 11) . Moreover, echocardiographic assessment of cardiovascular function in these animals revealed that cardiac output, ejection fraction, stroke volume, and fractional shortening of the left ventricle were all significantly decreased in CD4 ChAT − as compared to the CD4 ChAT + mice (Fig. 2d and Supplementary Table 5) . Together, these data indicate that ablation of ChAT expression in CD4 + cells increases vascular resistance and blood pressure in mice.
To study the mechanism of lymphocyte-derived acetylcholine in blood pressure regulation, we stably transfected Jurkat T lymphocytes with the pCMV6-mChAT vector engineered to express ChAT. These JT ChAT cells constitutively produced acetylcholine, whereas non-transfected Jurkat T cells did not produce detectable levels of acetylcholine (data not shown). It has been previously established that acetylcholine mediates vasodilation and hypotension by increasing intracellular Ca 2+ levels, and by activating Ser1177 phosphorylation of endothelial nitric oxide synthase (eNOS) to catalyze biosynthesis of NO from l-arginine 15 . To investigate whether JT ChAT cells stimulate these mechanisms of NOproduction here, vascular endothelial cells were pre-loaded with the calcium-responsive Fluo-4 dye and incubated with JT ChAT cells. We observed that incubation of JT ChAT cells with endothelial cells triggered a transient increase in endothelial Ca 2+ levels as measured by time-lapse fluorescent microscopy, whereas incubation of Jurkat T cells with endothelial cells failed to increase endothelial intracellular Ca 2+ levels (Supplementary Fig. 12 ). Incubation of primary ChAT-eGFP + lymphocytes derived from ChAT-eGFP reporter mice or JT ChAT cells with endothelial cells stimulated Ser1177 phosphorylation; this eNOS phosphorylation was attenuated by atropine ( Supplementary Figs. 13  and 14) . Addition of JT ChAT cells to endothelial cultures also increased production of nitrate and nitrite in the medium, the stable end products of enhanced NO production (Supplementary Fig. 15 ), mediated by exposure of endothelial cells to JT ChAT cells in vitro.
To determine whether JT ChAT cells mediate vasorelaxation in vivo, we measured blood pressure in anesthetized mice following insertion of a catheter into the left carotid artery. Infusion of JT ChAT cells significantly (P < 0.05) reduced mean arterial pressure within minutes, transiently producing up to a 10% decrease (Fig. 3a,c and Supplementary  Fig. 16 ). In contrast, administration of saline or Jurkat T cells failed to significantly decrease mean arterial pressure from baseline (Fig. 3b,c) . Administration of the muscarinic receptor blocker atropine, or the NOS inhibitor L-N G -nitroarginine methyl ester (L-NAME) attenuated JT ChAT cell-mediated decreases in blood pressure (Fig. 3b,c and Supplementary Figs. 16 and 17) . Administration of JT ChAT cells failed to significantly reduce mean arterial pressure from baseline in a group , Jurkat T lymphocytes (n = 13), or JT ChAT lymphocytes (n = 9). Mice were pre-treated with L-NAME (n = 7) or atropine (n = 8) as indicated. *P < 0.05, ***P < 0.001 (ANOVA with Bonferroni post hoc analysis). AUC, area under the curve.
npg l e t t e r s of mice with a genetic disruption of eNOS 16 (Supplementary Fig. 18 ), as expected from the prior experiments indicating that JT ChAT cells enhance endothelial NO production. Together, these results indicate that lymphocyte-derived acetylcholine can decrease blood pressure through a mechanism of endothelium-dependent vasorelaxation. The identification here of lymphocytes that contribute to blood pressure regulation reveals a previously unknown mechanism in cardiovascular homeostasis. The observation that genetic ablation of ChAT in CD4 + cells results in increased blood pressure in mice indicates that these cells play a homeostatic role in vasorelaxation and regulation of blood pressure. T cells have previously been linked to development of chronic vascular inflammation, atherosclerosis, and chronic increase in blood pressure [17] [18] [19] . Putative pathogenic mechanisms of T cells in hypertension, which are incompletely understood, include pro-inflammatory cytokine production, T-cell infiltration into vascular walls, and structural changes and stiffening of arterial walls secondary to inflammation 19, 20 . It has also been argued that specific T-cell subtypes may play distinct roles in hypertension. For example, regulatory T cells may attenuate hypertension by differentially modulating vascular inflammation 21 . Furthermore, it has been suggested that neural signaling originating in the brain stem and circumventricular organs may modulate the role of T lymphocytes in the development of experimental hypertension, and that T cells may play a role in the cerebral regulation of blood pressure 22 . The present findings offer an additional possibility, that a deficiency of CD4 T ChAT cells could contribute to an increase in blood pressure.
We and others have previously implicated CD4 T ChAT cells in neural control of inflammation 1, 23, 24 . Blood-borne CD4 T ChAT cells may deliver acetylcholine to cells devoid of direct cholinergic innervation, including vascular endothelial cells, which respond with NO-dependent vasodilation. Because of the physical constraints within 20-to 40-µm sized arterioles 25 , blood-borne CD4 T ChAT (which are on the order of ~10 µm in diameter) are likely capable of interacting directly with arteriolar endothelial cells, providing a cellular mechanism of acetylcholine-mediated arteriolar relaxation. Prior unexplained evidence of decreased ChAT expression in lymphocytes of hypertensive rats as compared to normotensive rats 26 support a role of blood-borne acetylcholine-producing lymphocytes in vasorelaxation. Our findings that CD4 ChAT − mice have an increase in blood pressure render plausible consideration of whether dysregulation of CD4 T ChAT cells and acetylcholine contributes to the pathogenesis of essential hypertension, and whether this mechanism may underlie hypertension in some cases. This improved understanding of lymphocyte-derived acetylcholine to mediate endothelial-dependent arterial relaxation suggests that it may be possible to enhance cellular acetylcholine release in the vasculature to therapeutically regulate local flow and blood pressure, insights that may have implications for developing a novel therapy for hypertension.
Moreover, CD4 T ChAT cells are regulated by neural signals traveling in the vagus and splenic nerves 1 . Ongoing studies of these mechanisms using implanted electrical nerve stimulators 27,28 may offer another strategy to control the activity of blood pressure-regulating ChAT + lymphocytes and prevent or reverse hypertension.
MeTHoDs
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Accession codes. The microarray data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus 29 and are accessible through GEO Series accession number GSE85915. Choline acetyltransferase (ChAT)-GFP (B6.Cg-Tg(RP23-268L19-EGFP)2Mik/J), ChAT-floxed (B6.129-Chattm1Jrs/J), and mice expressing Cre recombinase under the control of the endogenous CD4 promoter (CD4-Cre) were purchased from Jackson Laboratories (Bar Harbor, ME, USA). ChAT-floxed and CD4-Cre mice were crossed to generate mice genetically devoid of ChAT in the CD4 + population. ChAT-flox mice were crossed with animals expressing Cre recombinase under the control of the CD4 promoter (CD4-Cre + ChAT flox/flox ). In these animals, Cre recombinase is expressed in the double positive stage of the thymus, resulting in recombination in the T cell lineage 30 . Littermate controls were Cre − ChAT flox/flox . Animals were housed at 25 °C on a 12-h light/dark cycle, and acclimatized for at least 1 week before conducting experiments. Water and regular rodent chow were available ad libitum. BALB/c nude (nu/nu) mice 8 to 12 weeks old were obtained from Taconic. Male eNOS-deficient mice 16 were provided by J. Lundberg and E. Weitzberg, Karolinska Institutet, Stockholm, Sweden. Cells pooled from ChAT(BAC)-eGFP male and female mice were used for functional and phenotypic characterization. Animals were euthanized using CO 2 asphyxiation or cervical dislocation.
Flow cytometry and cell sorting. ChAT-eGFP + and ChAT-eGFP − cells were isolated from spleens of B6.Cg-Tg(RP23-268L19-eGFP)2Mik/J reporter mice by negative selection for CD4 + T cells followed by cell sorting by flow cytometry of the CD4 + CD44 hi CD62L lo population into eGFP + and eGFP − subsets 1 . For cell sorting experiments, an enriched CD4 + T-cell suspension was obtained by negative selection (CD4 + T-cell isolation kit II, Miltenyi) of spleen cells harvested from ChAT(BAC)-eGFP mice. The resulting enriched CD4 + cell suspension with >90% purity was then stained with anti-CD44 PE (eBioscience, 12-0441-81), anti-CD4 Pacific Orange (Invitrogen, MCD0430), anti-CD62L PE-Cy7 (eBioscience, 25-0621-82), and anti-CD19 APC (BD Biosciences, BDB550992) antibodies and 7-AAD solution. After gating out CD19 + and gating for CD62L lo CD44 hi cells, a ChAT-eGFP − and a ChAT-eGFP + fraction were collected using a FACSAria cell sorter (Becton Dickinson). The resulting fractions were CD4 + CD44 hi CD62L lo ChAT-eGFP − and CD4 + CD44 hi CD62L lo ChAT-eGFP + . 100-150,000 cells were sorted into FCS-containing cell culture medium. To improve purity, the freshly sorted cells were immediately sorted again using the same gating strategy, now directly into Trizol solution (Ambion) according to a modified ImmGen protocol (http://www.immgen.org/, https://www.immgen.org/Protocols/ImmGen%2 0Cell%20prep%20and%20sorting%20SOP.pdf) and subsequently frozen at −80 °C. Subsequent RNA isolation and Affymetrix Mouse ST 1.0 gene array hybridization experiments were performed by ImmGen 13 . Gene expression of CD4 + ChAT-eGFP + and CD4 + ChAT-eGFP + cells were analyzed separately and in the context of subsets of the publicly available ImmGen data set 13 using the R programming language (see below). Co-incubation experiments. Primary ChAT + lymphocytes or Jurkat T lymphocytes or pCMV6-mChAT-transfected Jurkat T cells (JT ChAT ) were coincubated with either human endothelial cells derived from pulmonary microcirculation or murine endothelial cells 31, 32 . Human PMEC-ST1.6R cells, kindly provided by C. James Kirkpatrick, Institute of Pathology, Johannes-Gutenberg University, Mainz, Germany, were seeded in 6-well plates in Endothelial Cell Growth Medium MV with supplement mix C-39225 (PromoCell) and experiments were performed at confluency. 2 × 10 6 ChAT + Jurkat T cells, 2 × 10 6 Jurkat T cells, 10 6 primary ChAT + lymphocytes or acetylcholine to a concentration of 100 µM in fresh medium was added to the endothelial cell culture, and cells incubated for 1 h. During co-culture experiments, cells were kept in a modular incubator chamber (Billups-Rothenberg, Del Mar, CA, USA) in a microenvironment within the chamber of 37 °C, 1% O 2 , 5% CO 2 , and 100% humidity 33 . Culture wells were subsequently washed twice with cold PBS and removal of non-adherent cells verified by microscopy. Protein was extracted using T-PER solution (Thermo Scientific) in the presence of HALT protease and phosphatase inhibitors (Thermo Scientific) according to manufacturer's instructions, and lysates stored at −80 °C until analysis using western blot. Membranes were probed with anti-peNOS (Cell Signalling, Cat. #9571) and anti-beta actin (GeneScript, Cat. #A00702) and developed with standard reagents (Pierce). Images were acquired on a GS-800 calibrated densitometer (Bio-Rad) and images analyzed using Image Studio software (Licor). Nitrite and nitrate in supernatants was measured using the Nitrate/Nitrite Colorimetric Assay Kit (Cayman Chemical, Ann Arbor, MI) according to manufacturer's instructions.
Murine lung microvascular endothelial cells were isolated and cultured as previously described 32 . In brief, fresh mouse lungs were rinsed, minced aseptically into small pieces, and digested in collagenase A (1 mg/mL, Worthington, NJ) at 37 °C for 60 min with occasional agitation. The single-cell suspension was filtered through sterile 40 µm cell strainer, washed in DMEM medium containing 10% FCS (10% FCS-DMEM), and incubated with magnetic beads conjugated with anti-mouse CD31 antibody 34 (Cat. #550274, Invitrogen, Carlsbad, CA) at 4 °C for 30 min. The bead-bound cells were recovered by placing the tube in a magnetic separation rack, washed with 10% FCS-DMEM, collected, and cultured in DMEM medium containing 10% FCS, 2 mM l-glutamine, 2 mM sodium pyruvate, 20 mM HEPES, 1% nonessential amino acids, 100 µg/mL streptomycin, 100 U/mL penicillin, 100 µg/mL heparin, and 100 µg/mL endothelial cell growth supplement. Endothelial cell phenotype was confirmed by positive staining of multiple endothelial-specific markers, including platelet endothelial cell adhesion molecule-1, eNOS, VE-cadherin, and, upon TNF exposure, E-selectin.
Calcium measurements. Endothelial cells derived from pulmonary microvasculature 31 were seeded onto glass coverslips 16-24 h before use in calcium imaging experiments. The coverslips were placed in a stainless steel imaging cell chamber (Attofluor Cell Chamber, Life Technologies, Grand Island, New York, USA). Within this chamber, the cells were washed with DMEM and loaded with the calcium-sensitive Fluo-4 NW in DMEM with probenecid (Fluo-4 NW Calcium Assay Kit, Molecular Probes, Eugene, Oregon, USA) for 45-60 min at 37 °C under 5% CO 2 . The imaging chamber was placed in a temperature-controlled Leiden chamber holder mounted on the stage of an Axiovert 200 M inverted fluorescence microscope (Carl Zeiss Microscopy, Thornwood, New York, USA) equipped with a 40×, 0.60 numerical aperture objective. Data were recorded every 10 s by illuminating the sample with light from a mercury lamp passing through an excitation filter (470 nm ± 40) before being directed at the cells by a 495-nm dichroic mirror. A single field was visualized in each experiment. Emitted light was captured by a cooled CCD camera (AxioCam monochromatic, Carl Zeiss Microscopy, Thornwood, New York, USA) following passage through a 525-nm ± 50 emission filter. The image acquisition setup was controlled by Axiovision 4.7 software (Carl Zeiss Microscopy, Thornwood, New York, USA).
After being placed on the microscope stage, cells were washed once with HEPES-buffered and indicator-free DMEM-containing acetylcholine esterase inhibitor. Baseline fluorescence was recorded for 2 min at which time cells were treated with 0.1 mM acetylcholine or co-incubated with 10 6 /mL of Jurkat T lymphocytes or pCMV6-mChAT vector-transfected Jurkat T lymphocytes. Intracellular fluorescence was monitored for an additional 5 min before concluding the experiment by treatment with 10 µM ionomycin (Sigma-Aldrich, St. Louis, MO, USA).
The acquired images were exported to ImageJ software for analysis. The mean fluorescence intensity values of 6-31 cells per experiment were extracted for each time point and normalized to the average baseline intensity. Individual npg
